NCT01954914View on ClinicalTrials.gov

Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Blood Stem Cell Harvest Failure
Interventions
DRUG

Plerixafor

Administration of a single dose of Plerixafor 240 µg/kg body weight of the donor SC in the evening at 10 PM after frustraneous stem cell apheresis on day 1.

Trial Locations (3)

50670

Cellex Gesellschaft für Zellgewinnung mbH Köln, Cologne

01307

Cellex Gesellschaft für Zellgewinnung mbH Dresden, Dresden

Universitätsklinikum Dresden, Medizinische Klinik I, Dresden

All Listed Sponsors
collaborator

University Hospital Carl Gustav Carus

OTHER

collaborator

Cellex Gesellschaft für Zellgewinnung mbH Dresden

UNKNOWN

collaborator

Cellex Gesellschaft für Zellgewinnung mbH Köln

UNKNOWN

lead

Technische Universität Dresden

OTHER

NCT01954914 - Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers | Biotech Hunter | Biotech Hunter